Herein, we reported the case of a 69-year-old woman diagnosed with pneumonia-type lung adenocarcinoma with EGFR 19Del who had a marked response to gefitinib initially but developed active pulmonary TB. Here, EGFR is linked to pulmonary tuberculosis.